ISLAMABAD, March 18 (Reuters) - Pakistan has reversed a
decision which had allowed uncapped prices for COVID-19 vaccines
imported by private firms, Health Minister Faisal Sultan said on
Thursday.
Pakistan, largely reliant on the GAVI/WHO COVAX initiative
for poorer nations, had early February allowed private companies
to import coronavirus vaccines and agreed to exempt such imports
from price caps.
"Now, however, there is a formula, already in vogue, to
determine max price," Sultan told Reuters. "So yes, there is a
price cap that DRAP (Drug Regulatory Authority of Pakistan) will
recommend and get approval for," he said.
(Reporting by Asif Shahzad; Editing by Toby Chopra)